The Riverside Company has invested in Executive Home Care Franchising (Executive Care), a leading provider of non-medical, in-home services for senior citizens and physically handicapped or injured individuals in need of daily living support.
Global investment bank GCA Altium has advised US-based corporate Ensign-Bickford Industries (EBI) on its acquisition of Cawood Scientific – a UK independent scientific group – from Waterland Private Equity. Cawood Scientific provides laboratory analysis to the agriculture, food, and environmental sectors, as well as contract research to support the development
BioAgilytix, a global contract research organisation (CRO), is to be further capitalised by Cinven, which will acquire a majority stake in the business, while current majority investor Cobepa, a Brussels-based private investment firm, will remain a significant minority investor in the Company. Cobepa and GHO Capital, a specialist investor in
Robert Bosch Venture Capital, the corporate venture capital company of the Bosch Group, has completed an investment in Variantyx Inc. Variantyx and Robert-Bosch Hospital join forces to improve personalised oncology treatment with plans to incorporate the Variantyx solution into the oncology treatment process. Variantyx provides clinicians with advanced diagnostics and
Gentronix, the UK-based contract research organisation (CRO) in the field of genetic toxicology, has raised GBP700,000 in a funding round led by existing investor Mercia to support its continued growth. The latest round, which includes a number of private investors, follows Gentronix’s recent acquisition of the Big Blue® transgenic mutation
Ceros Capital Markets, a division of Ceros Financial Services, announced that it has, has completed a USD17.14 million Series A2 Preferred Stock financing round for Aquyre Biosciences, a US company which has developed and built a disruptive medical diagnostic platform for on-site adequacy assessment of tissue biopsies.
International law firm McDermott Will & Emery has advised Apposite Capital, a healthcare specialist private equity investor, on its acquisition of a majority shareholding in CrestOptics, a specialist in the development and manufacture of advanced systems for fluorescence microscopy from XYence Capital and management. As part of the transaction, the
Arrowpoint Advisory’s Healthcare team has advised Veramed, a specialist biostatistics and programming Contract Research Organisation (CRO) serving pharmaceutical and biotech clients across the UK, Europe and US on its partnership with Livingbridge. Founded in 2012 by Matthew and Emma Jones and headquartered in London, Veramed provides statistical consulting, programming and
Private investment firm GI Partners is to sell Generate Life Sciences (Generate), a life sciences platform that provides reproductive and newborn stem cell (umbilical cord blood and tissue) services, to CooperCompanies (NYSE:COO). Generate Life Sciences was created by GI Partners in 2018 as the combination of California Cryobank Life Sciences,
M2 Orthopedics (M2O), a specialist in modern practice management for orthopaedic surgeons, has secured significant funding to broaden its ability to support orthopaedic practices.
12 November, 2026 – 5:00 pm
12 November, 2026 – 8:00 am
12 February, 2026 – 8:00 am
12 February, 2026 – 5:00 pm
